New test to predict relapse of testicular cancers

Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer. Assessing just three features of a common kind of testicular cancer — called non-seminomatous germ cell tumor — can identify those at most at risk of relapse even where there is no evidence of tumor spread. The researchers believe the test could be used in the clinic to make decisions about which patients should be given chemotherapy. (Mehr in: Cancer News — ScienceDaily)